{"ticker": {"uuid": "99963293-0a36-4d0e-9c93-0d0087202c85", "symbol": "TXMD", "name": "TherapeuticsMD Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of TherapeuticsMD Inc. (TXMD) fell 1.52% on Wednesday, closing at $1.94, despite a generally positive trading session for the broader stock market, with the NASDAQ Composite and Dow Jones Industrial Average both seeing gains. The company's stock currently sits 34.24% below", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-wednesday-when-compared-to-competitors-865fff34-78387941d1a5?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-15T17:29:00", "published_display": "15 Jul 2026 17:29", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Monday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) stock fell 1.50% to $1.97 on Monday, underperforming the broader market. Both the NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for TherapeuticsMD Inc. shares.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-monday-when-compared-to-competitors-6f3c5a01-7c8c546e95f7?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-13T23:38:12", "published_display": "13 Jul 2026 23:38", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock outperforms competitors on strong trading day", "summary": "Shares of TherapeuticsMD Inc. (TXMD) rallied 2.03% to $2.01 on Thursday, outperforming the broader market. The NASDAQ Composite Index and the Dow Jones Industrial Average also saw gains. The stock closed 31.86% below its 52-week high.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-outperforms-competitors-on-strong-trading-day-96f2825e-4fd67722332f?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-09T17:28:00", "published_display": "09 Jul 2026 17:28", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) News Flow", "summary": "This article provides an analysis of recent news and press releases concerning TherapeuticsMD (TXMD), focusing on how this information might impact stock performance and investor sentiment. It highlights key developments that could be relevant for current or prospective sharehold", "url": "https://www.moomoo.com/stock/TXMD-US/news?chain_id=Name1K9-3FXPhg.1l2mj00&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A58,%22f%22%3A%22www.moomoo.com%2Fcurrency%2FSGDUSD-FX%22%7D", "source_name": "Moomoo", "published_at": "2026-07-08T10:11:10", "published_display": "08 Jul 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) shares fell by 2.31% on Thursday, closing at $2.11. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising and the NASDAQ Composite Index falling. This marks the third consecutive day of losses for the stock.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-thursday-when-compared-to-competitors-01205bd6-d8c945c38d1e?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-02T17:27:00", "published_display": "02 Jul 2026 17:27", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (Nasdaq:TXMD) - Stock Analysis", "summary": "This Simply Wall St analysis of TherapeuticsMD (Nasdaq:TXMD) provides a detailed overview of the company's financial health, performance, and risks. The report highlights that TXMD is trading significantly below its estimated fair value but notes issues such as large one-off fina", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txmd/therapeuticsmd", "source_name": "Simply Wall Street", "published_at": "2026-07-01T08:10:57", "published_display": "01 Jul 2026 08:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) stock fell 1.34% on Tuesday, closing at $2.21, despite an overall positive day for the stock market. This decline broke a four-day winning streak for the company's shares. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains on the", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-tuesday-when-compared-to-competitors-c5c1030e-42dadd0993cb?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-30T17:30:00", "published_display": "30 Jun 2026 17:30", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22 - Stop Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRWxrSlRMZF9reTF3eDlSUU94aGVNMmhvVUFGRDdRcmtQLS15d1Z2QUp1U181Z3F1eHdkcXkzbVhiMEd2a1N4WnQzcmI0QzJrRmwwTHV2R2d5RkU4dnhBd08ybHNRbHQ4YmI3Mm5jOGk0QTcyeXBtdlFKT1pwZ0VhZEdtOFJNc0hNZ0xOQWZwMXBoUzE5dHAzdzAxY09CZDkxZndrUEdJUy1vb3ZhWVRoY01DNA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-28T01:40:41+00:00", "published_display": "28 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Gains Ground: Stock Rises 3.94% to $2.11, Testing Resistance at $2.22 - GEX Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNVmRzdjNwZmpOejZSYTZuc1pmTGhPVXo3Ymh6WTBUMDFWOV9HZ1FmdS1VMU5ScTlUQW5GU0QzbVhFc0NfQVhTaEF4cGwtd0VqQUpTX19VTUowY2tjVXZyMXlSdEdJc2pYdVFQWU1QLTdqZGVuYkN3UU1CWDdUV3UxQnVHcEZjdWRSVFZTNmlqY1JJdF9YalpZOWdwUE1VR3VVUzRfZ0JIc2VtbUItZUNWWkF3d1g5Yld5cmVudHZuaDlaUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22 - Fear Greed Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOenRkTTltT0llZEZtR1RzR3pOaHc5Nm0zUkhGR3daLWw4Q0FubVpSaERiU1dZUmlnRS15UDlqelZGZlRlRjduYkc2QktfWHV1bjEyS2lwaGpTeU9DbEJvdmZlSmxuVklLanZUT21qYXJLN0RIbVBlbEtYR0lZWDJ4MFloMWVIUGZVV282SXlnZExhblJWRndBQU84dHhpVG9UNmI4TXJVaG5Ub3hXWHVISk1NZF96QQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains", "summary": "TherapeuticsMD Inc. (TXMD) stock advanced 3.94% on Friday to $2.11, marking its third consecutive day of gains. Despite this rise, the stock underperformed compared to its competitors, as both the NASDAQ Composite Index and Dow Jones Industrial Average experienced declines. The i", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-friday-when-compared-to-competitors-despite-daily-gains-35b9977a-140a3e254e77?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-26T21:09:31", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article provides financial data for TherapeuticsMD, Inc. (NASDAQ: TXMD), specifically focusing on its forward price-to-book ratio. The content appears to be a stub or a data lookup result from TradingView, indicating that specific metrics for the company are available. It do", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:09:31", "published_display": "26 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article displays the \"Price to earnings forward\" metric for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial data page from TradingView, showing the company's ticker, market status, and providing navigation to various financial and community features, but th", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:20", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article focuses on the enterprise value to revenue forward ratio for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial snapshot or data point from TradingView, indicating a specific financial metric for the company. The content itself seems to be a data point", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T22:10:11", "published_display": "24 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of TherapeuticsMD Inc (TXMD), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 7.17 and is trading within a range of $1", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/technical", "source_name": "TradingKey", "published_at": "2026-06-24T05:09:32", "published_display": "24 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for TherapeuticsMD Inc (TXMD), detailing its current risk score of 1.71, ranking 143 out of 157 in the Pharmaceuticals industry. Key metrics such as beta value, volatility, maximum drawdown, and Sharpe Ratio are presented to give insights i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-23T03:39:15", "published_display": "23 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains", "summary": "TherapeuticsMD Inc. (TXMD) saw its stock rise 2.56% to $2.00 on Monday, ending a two-day losing streak. This performance occurred during a mixed trading session, with the Dow Jones Industrial Average gaining and the NASDAQ Composite Index falling. Despite its daily gains, the sto", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-monday-when-compared-to-competitors-despite-daily-gains-32d45363-c30aab543856?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-22T17:31:00", "published_display": "22 Jun 2026 17:31", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of TherapeuticsMD Inc (TXMD), noting its current valuation score of 7.83, which ranks it 119 out of 157 in the Pharmaceuticals industry. The company's P/E ratio stands at 125.32, indicating it is 17.44% below its recent high and 135.70% ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T04:40:35", "published_display": "19 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for TherapeuticsMD Inc (TXMD), noting that no earnings forecast score is currently available for the company, unlike the pharmaceuticals industry average of 7.84. It highlights key financial indicators like Market Cap and P/E TTM, and st", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T04:40:35", "published_display": "19 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of TherapeuticsMD Inc (TXMD), noting its stable financial status and high operating efficiency. The company's financial score is 8.57, ranking 46th in the Pharmaceuticals industry. TherapeuticsMD reported significant year-over-year incre", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T03:10:19", "published_display": "19 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Institutional Confidence", "summary": "TherapeuticsMD Inc (TXMD) has an institutional shareholding score of 3.00, placing it 94th out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 32.99%, marking a 14.39% quarter-over-quarter increase. James Simons is the largest instituti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T01:40:36", "published_display": "19 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of TherapeuticsMD Inc's (TXMD) dividend and stock split history. It notes that the company has distributed no dividends in the past five years and details a 50-to-1 merger-related stock split that occurred on May 6, 2022. The page also displays c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T16:10:35", "published_display": "17 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for TherapeuticsMD Inc (TXMD), focusing on its regional revenue contributions. As of the updated data on April 6, the company's revenue distribution shows the United States contributing 57.14% and Non-U.S. regions contributing 42.86%. The", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T16:10:35", "published_display": "17 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Gains 3.64%, Tests Resistance at $2.39 - Dealer Gamma", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQNHZiSm5lX21GbmVjYzRZVWJkMXl3M1YyWFFoRllYR1lubU5BbTd6SWRCS0hiZkN2MmZKaHlES24ycGRFNzRkbE5NVHl2bmgzbVpnLUR3MC1ubG9wcm9TZzNhOFR2bzdHOUNBeUk1QWkxYkUxUmVId3h6dFpXOWUzY1BOU1RLWHNvWDN4UUJHa2ZDMjd3cHdsenJqU3R1YjBxTXpoZg?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance Zone - Outside Reversal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTU1XQXFqci1EUm5HeUNCWm50cVVzUEtLakstNVJzSjNKYVI4ZC0yLVhGbWZpSnVnWEZ0N1RVOWY1WFJQNXQ0NjIwNDk0WW5abURsSElfbkhaOUhzRVdYbjhXbTVqdUh2eVhlWWJ3d1lfYnQxSHBucGxQaW15cEY4NXF6NHI1TEtUU1h4TTNEVnU3ai1iYmRFN2pUaU1FV2Q4ckM0X3Y2eDlxYW8yMUZXQkZvaWMtZTd3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance Zone - Total Put Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUHJNdzdNRko3Tll3QWhzNjhJNnM2Y3J2MDJzOGk0U3ZESWxWb3VreTNMRmlYNlFuNXJyVUdob3pYQXczNWpsMjdlTnd1ZmZhNmhUVGVzT1BBOVFEV1dPUDlscGFFWW5ERkdZd2Y4SDdHQ0lGbWFySVo4dlpNWngxOE1LZktZWEoxNUZxdE5qWTNvNUZ1U0FULUtTX0ZKZTh3X012M003QUtQTlNLXy1sWGxocHdaMmlpbjUw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Nears Support Amid Modest Selling Pressure - Triple EMA", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdXlnR2ZlTDVtWTVSbHFteTkzWXRTbl9OM2FIVWg0RG05ZDV5TGNPdU5sWldJaWJJVmhEcnhSQjNzVm42cktjclZuc2UyemktQmdFT2doOTVJSFFkRUowQ1c1eUJRZHV1VXV0WDZnVVVHV3lHTS1LcS1yQU1YZ3E4Z05JYVloY1I0MWR3RHdxb2ktM0QyMlI1VGJMbU1ua2l6RUk3Qw?oc=5", "source_name": "M\u011bsto B\u0159eclav", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Shares of TherapeuticsMD Inc. (TXMD) rose 1.52% to $2.00 on Thursday, breaking a three-day losing streak, despite the broader market seeing a mixed performance. The Dow Jones Industrial Average gained 1.73%, while the NASDAQ Composite Index fell 0.09%. This performance still mark", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-e98194d4-63e529e0f496?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-04T17:31:00", "published_display": "04 Jun 2026 17:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/news/therapeuticsmd-q1-earnings-snapshot-205140202.html", "source_name": "Associated Press", "published_at": "2026-05-12T20:51:40+00:00", "published_display": "12 May 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd (TXMD) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE56Q3FCVjIzbkJXel90cTFBLWE0REtGSWF6d0hCX0FuYzEyZlNTcko0d294MjZZSUpncGNoMUd1MVZUZVM1c1Y2VjhOYkhvajJELUE0?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:34:18+00:00", "published_display": "25 Apr 2025 00:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD - TXMD - Stock Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBpMFg0ZlRfNHA3QWhpNmsxTm5NU242RGdWVldpc21xWlRNZGtjaHdwUWl1S1lRQUtTemozR29CdDRhd0sxYkhla3Uwa2FZaXli?oc=5", "source_name": "The Motley Fool", "published_at": "2021-09-16T01:40:55+00:00", "published_display": "16 Sep 2021 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Appoints Hugh O\u2019Dowd as President", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQTVNiRkRtcExLQldGTXlqaDNHZXM1SlYzRnhnS3FnTTRCS2otQ1FuOXRqc2FVQVpCZ2pKemZvOXZvUld0NkZxaS14TXRuUDVubTUzMHB1cFlsLU9nYnRrdWZMZVZSR1lDM0ljR3RPVFlSenA0S0ZnRGFNeG0tS0FEa3hUQnpJd1JhV0FqTTI3SQ?oc=5", "source_name": "citybiz", "published_at": "2021-08-09T07:00:00+00:00", "published_display": "09 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Comedian Whitney Cummings Partners with TherapeuticsMD to Launch \"Just Say Vagina\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxORzMyMC0xMnJOYlJ6X01JSkhsYTFMMzE3NWFIYXlrTVhWbzYxYXdhbmNkaW0taUhWZWdsX1ZtR0Fqel9MdE1BblYyUlhZR21kSll0ZVJnMjBuRTNXRzJmbXB2ZHBNRlVrTnZjQnFoU3Y4dUk4M0NCZENrV2NpME9WSVduaE90Y1Y2eGl5MmtoUDk4cU5XNWp0N0lseUo5WmNxdFVzQ09EZTNoZTNtUzJHZ2hHTGxseFFuVmlBY0hNYw?oc=5", "source_name": "Nasdaq", "published_at": "2020-12-15T08:00:00+00:00", "published_display": "15 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd Stock Price Forecast. Should You Buy TXMD?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE9FRE5EZjFzZVJXQXJCbXVqMHlUNjE0UDVGSlpCYzVsWXhoankybE1ibTc1blREM0pjSDlWeGw3aVdJR1NtMjF4TQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-02T05:08:07+00:00", "published_display": "02 Dec 2020 05:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd (TXMD) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1ZNFVmVk1icnRXbjVEdWtNanpvN1lDWk8tRGNRd1JzZFZjQmpjUUFDQnduOFdhR3puWXB3dGdEVERzWjBlRVpVaFJwUFdBdw?oc=5", "source_name": "Stock Titan", "published_at": "2020-10-11T07:45:35+00:00", "published_display": "11 Oct 2020 07:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAJBVV95cUxNM3VfVXZUbFJIYU54OWU3TWJOZTBRZW1ONWgtZ0ZJWG81UGVwemIxR0t4ak11WTFFUXZ2WTlKRmFyc295OXpoWTc1NXplSWNKaTdjSEZJNS1RYW9NanFLelZ4NUxPUXBIbVo4aWMtRHVGcDdjaUxlOURWZ2toQmZhWWZGNnhEUVZialU2OWttRGI3Qk9haUZmbVhEZFBhdkZZNk9hbnROc1c4a2NISzE2TjFHaUZhM3JmVTkxd2stUmpSaHpPdUVieEJDaHRZdkpSc0diU3RuTXI4aDlISTdfZHZpWTlFdjd1UjRJdW9oSmVnQkh6YUJVUEpqSk9zMXdWQ1NodkV3TVpjZjN6ZGdyX2g1M2VaOHpVMExiWWVjajM0c2hvMTdYUw?oc=5", "source_name": "PR Newswire", "published_at": "2020-01-07T08:00:00+00:00", "published_display": "07 Jan 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXYTM (estradiol vaginal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOcUVlSnhYUUZZclpWMGo1VXpaT202VC1NUXhhaV9zd1gzdk9GaGViSHFGMTMwRzZYNk1RSEtYczVGQUpvSTlNZE9xa2I5QTlmempJaHl3SHZQZTdpaUg5MGNwV1FqTC1YRWV2cUo0cGxqczV5ZkFwOVFsYk9PSmJ5Z0hWVGVhZGNnbG14dA?oc=5", "source_name": "MultiVu", "published_at": "2018-05-30T07:00:00+00:00", "published_display": "30 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TXMD Stock Price and Chart \u2014 NASDAQ:TXMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5HTzJmbkZsNFVmTUMtanBCdUxvcm1fS3UzTzJ1U0l6U3RwTi0wdnFCTWlhTTltZjFna3dtbnpBVE5fTURlVERTRzRLOW1XMTNXR2hXbzR2eU9ZWDVC?oc=5", "source_name": "TradingView", "published_at": "2017-10-10T22:58:51+00:00", "published_display": "10 Oct 2017 22:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors", "summary": "Shares of TherapeuticsMD Inc. (TXMD) fell 1.52% on Wednesday, closing at $1.94, despite a generally positive trading session for the broader stock market, with the NASDAQ Composite and Dow Jones Industrial Average both seeing gains. The company's stock currently sits 34.24% below", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-wednesday-when-compared-to-competitors-865fff34-78387941d1a5?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-15T17:29:00", "published_display": "15 Jul 2026 17:29", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Monday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) stock fell 1.50% to $1.97 on Monday, underperforming the broader market. Both the NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for TherapeuticsMD Inc. shares.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-monday-when-compared-to-competitors-6f3c5a01-7c8c546e95f7?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-13T23:38:12", "published_display": "13 Jul 2026 23:38", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock outperforms competitors on strong trading day", "summary": "Shares of TherapeuticsMD Inc. (TXMD) rallied 2.03% to $2.01 on Thursday, outperforming the broader market. The NASDAQ Composite Index and the Dow Jones Industrial Average also saw gains. The stock closed 31.86% below its 52-week high.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-outperforms-competitors-on-strong-trading-day-96f2825e-4fd67722332f?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-09T17:28:00", "published_display": "09 Jul 2026 17:28", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) News Flow", "summary": "This article provides an analysis of recent news and press releases concerning TherapeuticsMD (TXMD), focusing on how this information might impact stock performance and investor sentiment. It highlights key developments that could be relevant for current or prospective sharehold", "url": "https://www.moomoo.com/stock/TXMD-US/news?chain_id=Name1K9-3FXPhg.1l2mj00&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A58,%22f%22%3A%22www.moomoo.com%2Fcurrency%2FSGDUSD-FX%22%7D", "source_name": "Moomoo", "published_at": "2026-07-08T10:11:10", "published_display": "08 Jul 2026 10:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) shares fell by 2.31% on Thursday, closing at $2.11. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising and the NASDAQ Composite Index falling. This marks the third consecutive day of losses for the stock.", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-thursday-when-compared-to-competitors-01205bd6-d8c945c38d1e?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-07-02T17:27:00", "published_display": "02 Jul 2026 17:27", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (Nasdaq:TXMD) - Stock Analysis", "summary": "This Simply Wall St analysis of TherapeuticsMD (Nasdaq:TXMD) provides a detailed overview of the company's financial health, performance, and risks. The report highlights that TXMD is trading significantly below its estimated fair value but notes issues such as large one-off fina", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-txmd/therapeuticsmd", "source_name": "Simply Wall Street", "published_at": "2026-07-01T08:10:57", "published_display": "01 Jul 2026 08:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors", "summary": "TherapeuticsMD Inc. (TXMD) stock fell 1.34% on Tuesday, closing at $2.21, despite an overall positive day for the stock market. This decline broke a four-day winning streak for the company's shares. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains on the", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-tuesday-when-compared-to-competitors-c5c1030e-42dadd0993cb?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-30T17:30:00", "published_display": "30 Jun 2026 17:30", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22 - Stop Run", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPRWxrSlRMZF9reTF3eDlSUU94aGVNMmhvVUFGRDdRcmtQLS15d1Z2QUp1U181Z3F1eHdkcXkzbVhiMEd2a1N4WnQzcmI0QzJrRmwwTHV2R2d5RkU4dnhBd08ybHNRbHQ4YmI3Mm5jOGk0QTcyeXBtdlFKT1pwZ0VhZEdtOFJNc0hNZ0xOQWZwMXBoUzE5dHAzdzAxY09CZDkxZndrUEdJUy1vb3ZhWVRoY01DNA?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-28T01:40:41+00:00", "published_display": "28 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Gains Ground: Stock Rises 3.94% to $2.11, Testing Resistance at $2.22 - GEX Level", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNVmRzdjNwZmpOejZSYTZuc1pmTGhPVXo3Ymh6WTBUMDFWOV9HZ1FmdS1VMU5ScTlUQW5GU0QzbVhFc0NfQVhTaEF4cGwtd0VqQUpTX19VTUowY2tjVXZyMXlSdEdJc2pYdVFQWU1QLTdqZGVuYkN3UU1CWDdUV3UxQnVHcEZjdWRSVFZTNmlqY1JJdF9YalpZOWdwUE1VR3VVUzRfZ0JIc2VtbUItZUNWWkF3d1g5Yld5cmVudHZuaDlaUQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Rallies 3.94% as Stock Approaches Key Resistance at $2.22 - Fear Greed Index", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOenRkTTltT0llZEZtR1RzR3pOaHc5Nm0zUkhGR3daLWw4Q0FubVpSaERiU1dZUmlnRS15UDlqelZGZlRlRjduYkc2QktfWHV1bjEyS2lwaGpTeU9DbEJvdmZlSmxuVklLanZUT21qYXJLN0RIbVBlbEtYR0lZWDJ4MFloMWVIUGZVV282SXlnZExhblJWRndBQU84dHhpVG9UNmI4TXJVaG5Ub3hXWHVISk1NZF96QQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-27T07:00:00+00:00", "published_display": "27 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains", "summary": "TherapeuticsMD Inc. (TXMD) stock advanced 3.94% on Friday to $2.11, marking its third consecutive day of gains. Despite this rise, the stock underperformed compared to its competitors, as both the NASDAQ Composite Index and Dow Jones Industrial Average experienced declines. The i", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-friday-when-compared-to-competitors-despite-daily-gains-35b9977a-140a3e254e77?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-26T21:09:31", "published_display": "26 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article provides financial data for TherapeuticsMD, Inc. (NASDAQ: TXMD), specifically focusing on its forward price-to-book ratio. The content appears to be a stub or a data lookup result from TradingView, indicating that specific metrics for the company are available. It do", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T06:09:31", "published_display": "26 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article displays the \"Price to earnings forward\" metric for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial data page from TradingView, showing the company's ticker, market status, and providing navigation to various financial and community features, but th", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:20", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of TherapeuticsMD, Inc. \u2013 NASDAQ:TXMD", "summary": "This article focuses on the enterprise value to revenue forward ratio for TherapeuticsMD, Inc. (NASDAQ: TXMD). It appears to be a financial snapshot or data point from TradingView, indicating a specific financial metric for the company. The content itself seems to be a data point", "url": "https://www.tradingview.com/symbols/NASDAQ-TXMD/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T22:10:11", "published_display": "24 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of TherapeuticsMD Inc (TXMD), focusing on its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 7.17 and is trading within a range of $1", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/technical", "source_name": "TradingKey", "published_at": "2026-06-24T05:09:32", "published_display": "24 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Risk Assessment: Volatility, Financial Risk & Investment Risk", "summary": "This article provides a risk assessment for TherapeuticsMD Inc (TXMD), detailing its current risk score of 1.71, ranking 143 out of 157 in the Pharmaceuticals industry. Key metrics such as beta value, volatility, maximum drawdown, and Sharpe Ratio are presented to give insights i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/risk-assesment", "source_name": "TradingKey", "published_at": "2026-06-23T03:39:15", "published_display": "23 Jun 2026 03:39", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Monday when compared to competitors despite daily gains", "summary": "TherapeuticsMD Inc. (TXMD) saw its stock rise 2.56% to $2.00 on Monday, ending a two-day losing streak. This performance occurred during a mixed trading session, with the Dow Jones Industrial Average gaining and the NASDAQ Composite Index falling. Despite its daily gains, the sto", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-monday-when-compared-to-competitors-despite-daily-gains-32d45363-c30aab543856?mod=goog_fin_scmw", "source_name": "MarketWatch", "published_at": "2026-06-22T17:31:00", "published_display": "22 Jun 2026 17:31", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of TherapeuticsMD Inc (TXMD), noting its current valuation score of 7.83, which ranks it 119 out of 157 in the Pharmaceuticals industry. The company's P/E ratio stands at 125.32, indicating it is 17.44% below its recent high and 135.70% ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-19T04:40:35", "published_display": "19 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for TherapeuticsMD Inc (TXMD), noting that no earnings forecast score is currently available for the company, unlike the pharmaceuticals industry average of 7.84. It highlights key financial indicators like Market Cap and P/E TTM, and st", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T04:40:35", "published_display": "19 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis", "summary": "This article analyzes the financial health of TherapeuticsMD Inc (TXMD), noting its stable financial status and high operating efficiency. The company's financial score is 8.57, ranking 46th in the Pharmaceuticals industry. TherapeuticsMD reported significant year-over-year incre", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/financial-health", "source_name": "TradingKey", "published_at": "2026-06-19T03:10:19", "published_display": "19 Jun 2026 03:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Institutional Confidence", "summary": "TherapeuticsMD Inc (TXMD) has an institutional shareholding score of 3.00, placing it 94th out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 32.99%, marking a 14.39% quarter-over-quarter increase. James Simons is the largest instituti", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T01:40:36", "published_display": "19 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of TherapeuticsMD Inc's (TXMD) dividend and stock split history. It notes that the company has distributed no dividends in the past five years and details a 50-to-1 merger-related stock split that occurred on May 6, 2022. The page also displays c", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T16:10:35", "published_display": "17 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc (TXMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for TherapeuticsMD Inc (TXMD), focusing on its regional revenue contributions. As of the updated data on April 6, the company's revenue distribution shows the United States contributing 57.14% and Non-U.S. regions contributing 42.86%. The", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-txmd/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T16:10:35", "published_display": "17 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Gains 3.64%, Tests Resistance at $2.39 - Dealer Gamma", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQNHZiSm5lX21GbmVjYzRZVWJkMXl3M1YyWFFoRllYR1lubU5BbTd6SWRCS0hiZkN2MmZKaHlES24ycGRFNzRkbE5NVHl2bmgzbVpnLUR3MC1ubG9wcm9TZzNhOFR2bzdHOUNBeUk1QWkxYkUxUmVId3h6dFpXOWUzY1BOU1RLWHNvWDN4UUJHa2ZDMjd3cHdsenJqU3R1YjBxTXpoZg?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance Zone - Outside Reversal", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNTU1XQXFqci1EUm5HeUNCWm50cVVzUEtLakstNVJzSjNKYVI4ZC0yLVhGbWZpSnVnWEZ0N1RVOWY1WFJQNXQ0NjIwNDk0WW5abURsSElfbkhaOUhzRVdYbjhXbTVqdUh2eVhlWWJ3d1lfYnQxSHBucGxQaW15cEY4NXF6NHI1TEtUU1h4TTNEVnU3ai1iYmRFN2pUaU1FV2Q4ckM0X3Y2eDlxYW8yMUZXQkZvaWMtZTd3?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. (TXMD) Gains Ground as Shares Push Toward Resistance Zone - Total Put Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQUHJNdzdNRko3Tll3QWhzNjhJNnM2Y3J2MDJzOGk0U3ZESWxWb3VreTNMRmlYNlFuNXJyVUdob3pYQXczNWpsMjdlTnd1ZmZhNmhUVGVzT1BBOVFEV1dPUDlscGFFWW5ERkdZd2Y4SDdHQ0lGbWFySVo4dlpNWngxOE1LZktZWEoxNUZxdE5qWTNvNUZ1U0FULUtTX0ZKZTh3X012M003QUtQTlNLXy1sWGxocHdaMmlpbjUw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD (TXMD) Nears Support Amid Modest Selling Pressure - Triple EMA", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOdXlnR2ZlTDVtWTVSbHFteTkzWXRTbl9OM2FIVWg0RG05ZDV5TGNPdU5sWldJaWJJVmhEcnhSQjNzVm42cktjclZuc2UyemktQmdFT2doOTVJSFFkRUowQ1c1eUJRZHV1VXV0WDZnVVVHV3lHTS1LcS1yQU1YZ3E4Z05JYVloY1I0MWR3RHdxb2ktM0QyMlI1VGJMbU1ua2l6RUk3Qw?oc=5", "source_name": "M\u011bsto B\u0159eclav", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors despite daily gains", "summary": "Shares of TherapeuticsMD Inc. (TXMD) rose 1.52% to $2.00 on Thursday, breaking a three-day losing streak, despite the broader market seeing a mixed performance. The Dow Jones Industrial Average gained 1.73%, while the NASDAQ Composite Index fell 0.09%. This performance still mark", "url": "https://www.marketwatch.com/data-news/therapeuticsmd-inc-stock-underperforms-thursday-when-compared-to-competitors-despite-daily-gains-e98194d4-63e529e0f496?mod=mw_quote_news", "source_name": "MarketWatch", "published_at": "2026-06-04T17:31:00", "published_display": "04 Jun 2026 17:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD: Q1 Earnings Snapshot", "summary": "", "url": "https://finance.yahoo.com/news/therapeuticsmd-q1-earnings-snapshot-205140202.html", "source_name": "Associated Press", "published_at": "2026-05-12T20:51:40+00:00", "published_display": "12 May 2026 20:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd (TXMD) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE56Q3FCVjIzbkJXel90cTFBLWE0REtGSWF6d0hCX0FuYzEyZlNTcko0d294MjZZSUpncGNoMUd1MVZUZVM1c1Y2VjhOYkhvajJELUE0?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:34:18+00:00", "published_display": "25 Apr 2025 00:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD - TXMD - Stock Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBpMFg0ZlRfNHA3QWhpNmsxTm5NU242RGdWVldpc21xWlRNZGtjaHdwUWl1S1lRQUtTemozR29CdDRhd0sxYkhla3Uwa2FZaXli?oc=5", "source_name": "The Motley Fool", "published_at": "2021-09-16T01:40:55+00:00", "published_display": "16 Sep 2021 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Appoints Hugh O\u2019Dowd as President", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQTVNiRkRtcExLQldGTXlqaDNHZXM1SlYzRnhnS3FnTTRCS2otQ1FuOXRqc2FVQVpCZ2pKemZvOXZvUld0NkZxaS14TXRuUDVubTUzMHB1cFlsLU9nYnRrdWZMZVZSR1lDM0ljR3RPVFlSenA0S0ZnRGFNeG0tS0FEa3hUQnpJd1JhV0FqTTI3SQ?oc=5", "source_name": "citybiz", "published_at": "2021-08-09T07:00:00+00:00", "published_display": "09 Aug 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Comedian Whitney Cummings Partners with TherapeuticsMD to Launch \"Just Say Vagina\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxORzMyMC0xMnJOYlJ6X01JSkhsYTFMMzE3NWFIYXlrTVhWbzYxYXdhbmNkaW0taUhWZWdsX1ZtR0Fqel9MdE1BblYyUlhZR21kSll0ZVJnMjBuRTNXRzJmbXB2ZHBNRlVrTnZjQnFoU3Y4dUk4M0NCZENrV2NpME9WSVduaE90Y1Y2eGl5MmtoUDk4cU5XNWp0N0lseUo5WmNxdFVzQ09EZTNoZTNtUzJHZ2hHTGxseFFuVmlBY0hNYw?oc=5", "source_name": "Nasdaq", "published_at": "2020-12-15T08:00:00+00:00", "published_display": "15 Dec 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd Stock Price Forecast. Should You Buy TXMD?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE9FRE5EZjFzZVJXQXJCbXVqMHlUNjE0UDVGSlpCYzVsWXhoankybE1ibTc1blREM0pjSDlWeGw3aVdJR1NtMjF4TQ?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-02T05:08:07+00:00", "published_display": "02 Dec 2020 05:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Therapeuticsmd (TXMD) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE1ZNFVmVk1icnRXbjVEdWtNanpvN1lDWk8tRGNRd1JzZFZjQmpjUUFDQnduOFdhR3puWXB3dGdEVERzWjBlRVpVaFJwUFdBdw?oc=5", "source_name": "Stock Titan", "published_at": "2020-10-11T07:45:35+00:00", "published_display": "11 Oct 2020 07:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAJBVV95cUxNM3VfVXZUbFJIYU54OWU3TWJOZTBRZW1ONWgtZ0ZJWG81UGVwemIxR0t4ak11WTFFUXZ2WTlKRmFyc295OXpoWTc1NXplSWNKaTdjSEZJNS1RYW9NanFLelZ4NUxPUXBIbVo4aWMtRHVGcDdjaUxlOURWZ2toQmZhWWZGNnhEUVZialU2OWttRGI3Qk9haUZmbVhEZFBhdkZZNk9hbnROc1c4a2NISzE2TjFHaUZhM3JmVTkxd2stUmpSaHpPdUVieEJDaHRZdkpSc0diU3RuTXI4aDlISTdfZHZpWTlFdjd1UjRJdW9oSmVnQkh6YUJVUEpqSk9zMXdWQ1NodkV3TVpjZjN6ZGdyX2g1M2VaOHpVMExiWWVjajM0c2hvMTdYUw?oc=5", "source_name": "PR Newswire", "published_at": "2020-01-07T08:00:00+00:00", "published_display": "07 Jan 2020 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TherapeuticsMD Announces FDA Approval of TX-004HR: IMVEXXYTM (estradiol vaginal", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOcUVlSnhYUUZZclpWMGo1VXpaT202VC1NUXhhaV9zd1gzdk9GaGViSHFGMTMwRzZYNk1RSEtYczVGQUpvSTlNZE9xa2I5QTlmempJaHl3SHZQZTdpaUg5MGNwV1FqTC1YRWV2cUo0cGxqczV5ZkFwOVFsYk9PSmJ5Z0hWVGVhZGNnbG14dA?oc=5", "source_name": "MultiVu", "published_at": "2018-05-30T07:00:00+00:00", "published_display": "30 May 2018 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TXMD Stock Price and Chart \u2014 NASDAQ:TXMD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5HTzJmbkZsNFVmTUMtanBCdUxvcm1fS3UzTzJ1U0l6U3RwTi0wdnFCTWlhTTltZjFna3dtbnpBVE5fTURlVERTRzRLOW1XMTNXR2hXbzR2eU9ZWDVC?oc=5", "source_name": "TradingView", "published_at": "2017-10-10T22:58:51+00:00", "published_display": "10 Oct 2017 22:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 69, "total_relevant": 38, "sentiment_summary": {"positive": 9, "negative": 7, "neutral": 22, "score": 48, "total": 38, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 88, "events": [{"event": "general", "label": "Market update", "weight": 19.3, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 3.1, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 2.0, "latest_week": "2026-07-10", "one_week_move": -5.2, "four_week_move": -9.1, "twelve_week_move": -3.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.40992, "market_dynamics_buy_signal": false, "relative_strength": -1.908446, "fair_value_gap": 6.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 41.9166, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.2% over one week, -9.1% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketWatch", "count": 8}, {"label": "TradingKey", "count": 8}, {"label": "dars.gov.et", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Stock Titan", "count": 2}, {"label": "Moomoo", "count": 1}, {"label": "Simply Wall Street", "count": 1}, {"label": "Donan\u0131mHaber", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 38}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 5}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "88/100 classification confidence."}, {"label": "Company focus", "value": "38", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "9", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.2% over one week, -9.1% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors"}], "updated_at": "2026-07-16T03:03:14.098256+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}